Global Measles, Mumps and Rubella (MMR) Vaccines Market Insights and Forecast to 2028

Global Measles, Mumps and Rubella (MMR) Vaccines Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Measles, Mumps and Rubella (MMR) Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monovalent Vaccine
1.2.3 Polyvalent Vaccine
1.3 Market by Application
1.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Immune Center
1.3.3 Vaccine Development Agencies and Organizations
1.3.4 Hospital
1.3.5 Laboratory
1.3.6 Biotechnology and Biopharmaceutical Companies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region
2.4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Measles, Mumps and Rubella (MMR) Vaccines by Region (2023-2028)
2.5 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region
2.5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2017-2022)
2.5.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Manufacturers
3.1.1 Global Top Measles, Mumps and Rubella (MMR) Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Measles, Mumps and Rubella (MMR) Vaccines in 2021
3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Manufacturers
3.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Measles, Mumps and Rubella (MMR) Vaccines Revenue in 2021
3.3 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type
4.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type
4.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Type
4.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Type (2017-2022)
4.3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application
5.1.1 Global Measles, Mumps and Rubella (MMR) Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Measles, Mumps and Rubella (MMR) Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application
5.2.1 Global Measles, Mumps and Rubella (MMR) Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Measles, Mumps and Rubella (MMR) Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application
5.3.1 Global Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2017-2022)
5.3.2 Global Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type
6.1.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2028)
6.1.2 North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2028)
6.2 North America Measles, Mumps and Rubella (MMR) Vaccines Market Size by Application
6.2.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2017-2028)
6.2.2 North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2028)
6.3 North America Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country
6.3.1 North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2028)
6.3.2 North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type
7.1.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2028)
7.1.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2028)
7.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size by Application
7.2.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2017-2028)
7.2.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2028)
7.3 Europe Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country
7.3.1 Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2028)
7.3.2 Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type
8.1.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size by Application
8.2.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Market Size by Region
8.3.1 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type
9.1.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2028)
9.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Size by Application
9.2.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2028)
9.3 Latin America Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country
9.3.1 Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Size by Type
10.1.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Size by Application
10.2.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Market Size by Country
10.3.1 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Medlmmune
11.1.1 Medlmmune Corporation Information
11.1.2 Medlmmune Overview
11.1.3 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medlmmune Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Overview
11.2.3 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson & Johnson Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Recent Developments
11.5 Serum
11.5.1 Serum Corporation Information
11.5.2 Serum Overview
11.5.3 Serum Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Serum Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Serum Recent Developments
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Corporation Information
11.6.2 Bavarian Nordic Overview
11.6.3 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bavarian Nordic Recent Developments
11.7 Astellas Pharma
11.7.1 Astellas Pharma Corporation Information
11.7.2 Astellas Pharma Overview
11.7.3 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Astellas Pharma Recent Developments
11.8 Emergent BioSolutions
11.8.1 Emergent BioSolutions Corporation Information
11.8.2 Emergent BioSolutions Overview
11.8.3 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Emergent BioSolutions Recent Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Corporation Information
11.9.2 GlaxoSmithKline Overview
11.9.3 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GlaxoSmithKline Recent Developments
11.10 Pfizer
11.10.1 Pfizer Corporation Information
11.10.2 Pfizer Overview
11.10.3 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Pfizer Recent Developments
11.11 CSL
11.11.1 CSL Corporation Information
11.11.2 CSL Overview
11.11.3 CSL Measles, Mumps and Rubella (MMR) Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 CSL Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 CSL Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Chain Analysis
12.2 Measles, Mumps and Rubella (MMR) Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Measles, Mumps and Rubella (MMR) Vaccines Production Mode & Process
12.4 Measles, Mumps and Rubella (MMR) Vaccines Sales and Marketing
12.4.1 Measles, Mumps and Rubella (MMR) Vaccines Sales Channels
12.4.2 Measles, Mumps and Rubella (MMR) Vaccines Distributors
12.5 Measles, Mumps and Rubella (MMR) Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Measles, Mumps and Rubella (MMR) Vaccines Industry Trends
13.2 Measles, Mumps and Rubella (MMR) Vaccines Market Drivers
13.3 Measles, Mumps and Rubella (MMR) Vaccines Market Challenges
13.4 Measles, Mumps and Rubella (MMR) Vaccines Market Restraints
14 Key Findings in The Global Measles, Mumps and Rubella (MMR) Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Monovalent Vaccine
Table 3. Major Manufacturers of Polyvalent Vaccine
Table 4. Global Measles, Mumps and Rubella (MMR) Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2017-2022) & (K Doses)
Table 7. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2017-2022)
Table 8. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2023-2028) & (K Doses)
Table 9. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Market Share by Region (2023-2028)
Table 10. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2017-2022)
Table 12. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Market Share by Region (2023-2028)
Table 14. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Manufacturers (2017-2022) & (K Doses)
Table 15. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Manufacturers (2017-2022)
Table 16. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Manufacturers (2017-2022)
Table 18. Measles, Mumps and Rubella (MMR) Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)
Table 19. Global Measles, Mumps and Rubella (MMR) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Measles, Mumps and Rubella (MMR) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Measles, Mumps and Rubella (MMR) Vaccines as of 2021)
Table 21. Measles, Mumps and Rubella (MMR) Vaccines Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Measles, Mumps and Rubella (MMR) Vaccines Product Offered
Table 23. Date of Manufacturers Enter into Measles, Mumps and Rubella (MMR) Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2022) & (K Doses)
Table 26. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2023-2028) & (K Doses)
Table 27. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2017-2022)
Table 28. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Type (2023-2028)
Table 29. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2017-2022)
Table 32. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Type (2023-2028)
Table 33. Measles, Mumps and Rubella (MMR) Vaccines Price by Type (2017-2022) & (USD/Dose)
Table 34. Global Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)
Table 35. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2017-2022) & (K Doses)
Table 36. Global Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2023-2028) & (K Doses)
Table 37. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2017-2022)
Table 38. Global Measles, Mumps and Rubella (MMR) Vaccines Sales Share by Application (2023-2028)
Table 39. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2017-2022)
Table 42. Global Measles, Mumps and Rubella (MMR) Vaccines Revenue Share by Application (2023-2028)
Table 43. Measles, Mumps and Rubella (MMR) Vaccines Price by Application (2017-2022) & (USD/Dose)
Table 44. Global Measles, Mumps and Rubella (MMR) Vaccines Price Forecast by Application (2023-2028) & (USD/Dose)
Table 45. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2022) & (K Doses)
Table 46. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2023-2028) & (K Doses)
Table 47. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2017-2022) & (K Doses)
Table 50. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2023-2028) & (K Doses)
Table 51. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2022) & (K Doses)
Table 54. North America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2023-2028) & (K Doses)
Table 55. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2022) & (K Doses)
Table 58. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2023-2028) & (K Doses)
Table 59. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2017-2022) & (K Doses)
Table 62. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2023-2028) & (K Doses)
Table 63. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2022) & (K Doses)
Table 66. Europe Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2023-2028) & (K Doses)
Table 67. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2022) & (K Doses)
Table 70. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2023-2028) & (K Doses)
Table 71. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2017-2022) & (K Doses)
Table 74. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2023-2028) & (K Doses)
Table 75. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2017-2022) & (K Doses)
Table 78. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Sales by Region (2023-2028) & (K Doses)
Table 79. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Measles, Mumps and Rubella (MMR) Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2022) & (K Doses)
Table 82. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2023-2028) & (K Doses)
Table 83. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2017-2022) & (K Doses)
Table 86. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2023-2028) & (K Doses)
Table 87. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2022) & (K Doses)
Table 90. Latin America Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2023-2028) & (K Doses)
Table 91. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2017-2022) & (K Doses)
Table 94. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Type (2023-2028) & (K Doses)
Table 95. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2017-2022) & (K Doses)
Table 98. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Application (2023-2028) & (K Doses)
Table 99. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2017-2022) & (K Doses)
Table 102. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Sales by Country (2023-2028) & (K Doses)
Table 103. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Measles, Mumps and Rubella (MMR) Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 105. Medlmmune Corporation Information
Table 106. Medlmmune Description and Major Businesses
Table 107. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 108. Medlmmune Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Medlmmune Recent Developments
Table 110. Johnson & Johnson Corporation Information
Table 111. Johnson & Johnson Description and Major Businesses
Table 112. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Johnson & Johnson Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Johnson & Johnson Recent Developments
Table 115. Merck Corporation Information
Table 116. Merck Description and Major Businesses
Table 117. Merck Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Merck Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Merck Recent Developments
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Major Businesses
Table 122. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. Sanofi Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sanofi Recent Developments
Table 125. Serum Corporation Information
Table 126. Serum Description and Major Businesses
Table 127. Serum Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. Serum Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Serum Recent Developments
Table 130. Bavarian Nordic Corporation Information
Table 131. Bavarian Nordic Description and Major Businesses
Table 132. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Bavarian Nordic Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Bavarian Nordic Recent Developments
Table 135. Astellas Pharma Corporation Information
Table 136. Astellas Pharma Description and Major Businesses
Table 137. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. Astellas Pharma Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Astellas Pharma Recent Developments
Table 140. Emergent BioSolutions Corporation Information
Table 141. Emergent BioSolutions Description and Major Businesses
Table 142. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Emergent BioSolutions Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Emergent BioSolutions Recent Developments
Table 145. GlaxoSmithKline Corporation Information
Table 146. GlaxoSmithKline Description and Major Businesses
Table 147. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 148. GlaxoSmithKline Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. GlaxoSmithKline Recent Developments
Table 150. Pfizer Corporation Information
Table 151. Pfizer Description and Major Businesses
Table 152. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 153. Pfizer Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Pfizer Recent Developments
Table 155. CSL Corporation Information
Table 156. CSL Description and Major Businesses
Table 157. CSL Measles, Mumps and Rubella (MMR) Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 158. CSL Measles, Mumps and Rubella (MMR) Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. CSL Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Measles, Mumps and Rubella (MMR) Vaccines Distributors List
Table 163. Measles, Mumps and Rubella (MMR) Vaccines Customers List
Table 164.

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs